$69.16
1.011.48%
Ult. Agg.: Oct 27, 11:27 AM
BridgeBio Pharma (BBIO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.59 | $-0.63 | $-0.67 | $-0.82 |
| Actual | $-0.78 | $-0.84 | $-1.00 | $-0.95 |
| Surprise | -32.2% | -33.3% | -49.3% | -15.8% |
| Revenue | ||||
| Estimate | $220.3M | $178.8M | $149.5M | $105.8M |
| Actual | $243.7M | $194.5M | $154.2M | $120.7M |
| Surprise | +10.6% | +8.76% | +3.16% | +14.1% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.57 | $-0.43 | $-0.41 | $-0.19 |
| Revenue | ||||
| Consensus | $295.9M | $308.4M | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $-0.78 | $-0.59 | -32.2 % |
| Q1 | May 7, 2026 | $-0.84 | $-0.63 | -33.3 % |
| Q4 | Feb 24, 2026 | $-1.00 | $-0.67 | -49.3 % |
| Q3 | Oct 29, 2025 | $-0.95 | $-0.82 | -15.8 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $243.68M | $220.30M | 10.6 % |
| Q1 | May 7, 2026 | $194.52M | $178.85M | 8.76 % |
| Q4 | Feb 24, 2026 | $154.18M | $149.45M | 3.16 % |
| Q3 | Oct 29, 2025 | $120.70M | $105.82M | 14.1 % |